SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950116-03-004716
Filing Date
2003-12-03
Accepted
2003-12-03 17:07:16
Documents
1
Period of Report
2003-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 p328615_ex.html 4  
1 FORM 4 p328615_ex.xml 4 3295
  Complete submission text file 0000950116-03-004716.txt   5198
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENEREX BIOTECHNOLOGY CORP 33 HARBOR SQUARE STE 202 TORONTO ONTARIO CANADA M5J2G2
Business Address 33 HARBOUR SQUARE STE 202 TORONTO A6 M5H2G2 4163642551
GLUSKIN ANNA E (Reporting) CIK: 0001125857 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 031035779